Skip to main content
Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.36
+0.02 (0.14%)
Mar 9, 2026, 3:40 PM EDT - Market open

Amicus Therapeutics Revenue

In the year 2025, Amicus Therapeutics had annual revenue of $634.21M with 20.05% growth. Amicus Therapeutics had revenue of $185.21M in the quarter ending December 31, 2025, with 23.72% growth.

Revenue (ttm)
$634.21M
Revenue Growth
+20.05%
P/S Ratio
7.10
Revenue / Employee
$1,241,115
Employees
511
Market Cap
4.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025634.21M105.92M20.05%
Dec 31, 2024528.30M128.94M32.29%
Dec 31, 2023399.36M70.12M21.30%
Dec 31, 2022329.23M23.72M7.76%
Dec 31, 2021305.51M44.63M17.11%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PTC Therapeutics 1.73B
TG Therapeutics 616.29M
Mirum Pharmaceuticals 521.31M
Ligand Pharmaceuticals 268.09M
Crinetics Pharmaceuticals 7.70M
CG Oncology 4.04M
Revenue Rankings

FOLD News

More News